Drugs · acquisition-cost intelligence
lidocaine
· ingredient lidocaineAmides· LIDOCAINE 50 mg/g; LIDOCAINE 5 g/100g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.15755
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$0.12960 |
| ALCEMISTE | $0.05101 | −$0.10650 |
| Lidocaine Viscous | $0.07984 | −$0.07770 |
| Lidocaine | $0.09024 | −$0.06730 |
| Cadira Compliant Blood Stat | $0.21848 | +$0.06090 |
| LIDOCAINE HCl | $0.24343 | +$0.08590 |
| Lidocaine | $0.35160 | +$0.19410 |
| Acolye Numbing Cream Anorectal(Hemorrhoidal) Cream | $0.35967 | +$0.20210 |
Medicare Part D coverage · CY2026
On 289 plan formularies · typical tier 4
Prior auth 68% · Step therapy 0% · Quantity limit 91% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.